CDKN2A and cancer: NRF2 encoded by Nfe2l2 is an antioxidant defense system that appears to be a plausible candidate to trigger the pro-tumoral action of p16Ink4a Hi senescent cells as it induces cellular senescence in fibroblasts47 and confers a selective advantage in cancer cells48.